Chemists unite! InChI is now built for collaboration — and scale
The International Chemical Identifier (InChI) is going through a massive transformation — meet two of its champions who are helping bring InChI to the masses.
Votre navigateur n’est malheureusement pas entièrement pris en charge. Si vous avez la possibilité de le faire, veuillez passer à une version plus récente ou utiliser Mozilla Firefox, Microsoft Edge, Google Chrome, ou Safari 14 ou plus récent. Si vous n’y parvenez pas et que vous avez besoin d’aide, veuillez nous faire part de vos commentaires.
Nous vous serions reconnaissants de nous faire part de vos commentaires sur cette nouvelle expérience.Faites-nous part de votre opinion S’ouvre dans une nouvelle fenêtre
Discover the latest articles, resources and webinars
The International Chemical Identifier (InChI) is going through a massive transformation — meet two of its champions who are helping bring InChI to the masses.
Discover how research-intensive companies are navigating the perils and pitfalls of AI. Hear from experts about AI changing innovation and R&D processes to drive better business outcomes.
Watch the webinars:
Johnson Matthey on foundations for effective AI S’ouvre dans une nouvelle fenêtre
The perils and pitfalls of generative AI for R&D S’ouvre dans une nouvelle fenêtre
Drug repurposing can significantly reduce timelines and cost compared with de novo drug development. Explore drug repurposing topics, including:
3 approaches to drug repurposing
Drug repurposing methods
Drug repurposing challenges
Dive into innovative methodologies, cutting-edge research and ethical considerations aimed at fostering a future without animal testing in a recorded webinar series featuring the following experts:
Successful alternatives to animal testing S’ouvre dans une nouvelle fenêtre
Gail Van Norman, Professor Emeritus, University of Washington
Thomas Hartung, Johns Hopkins Bloomberg School of Public Health
Successful AI alternatives to animal testing S’ouvre dans une nouvelle fenêtre
Dr. Weida Tong, FDA’s National Center for Toxicological Research
Matthew Clark, Charles River Laboratories
Medical device regulation (MDR) compliance is a challenge for medical device companies. Review key topics in MDR and access a popular webinar series to avoid errors in securing device approvals:
MDR throughout the product lifecycle
Trends and challenges in MDR
Why do regulatory submissions and applications get rejected?
MDR webinars on navigating compliance challenges and achieving certification